Anúncio
Anúncio

LFMD

LFMD logo

LifeMD, Inc. Common Stock

3.87
USD
Patrocinado
-0.13
-3.37%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

3.89

+0.02
+0.65%

Relatórios de Lucros LFMD

Rácio de surpresa positiva

LFMD separação 7 de 20 últimas estimativas.

35%

Próximo Relatório

Data do Próximo Relatório
09 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$49.54M
/
-$0.03
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-17.66%
/
-57.14%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-22.89%
/
+50.00%

LifeMD, Inc. Common Stock earnings per share and revenue

On 17 de nov. de 2025, LFMD reported earnings of -0.07 USD per share (EPS) for Q3 25, missing the estimate of -0.04 USD, resulting in a -47.06% surprise. Revenue reached 60.17 milhão, compared to an expected 63.31 milhão, with a -4.95% difference. The market reacted with a -13.53% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analistas forecast an EPS of -0.03 USD, with revenue projected to reach 49.54 milhão USD, implying an diminuir of -57.14% EPS, and diminuir of -17.66% in Revenue from the last quarter.
FAQ
For Q3 2025, LifeMD, Inc. Common Stock reported EPS of -$0.07, missing estimates by -47.06%, and revenue of $60.17M, -4.95% below expectations.
The stock price moved down -13.53%, changed from $4.73 before the earnings release to $4.09 the day after.
The next earning report is scheduled for 09 de mar. de 2026.
Based on 9 analistas, LifeMD, Inc. Common Stock is expected to report EPS of -$0.03 and revenue of $49.54M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio